Luna Pharma Consulting
Business Coaches
Luna Pharma Consulting
25 Eccleston Pl, London
# Luna Pharma Consulting
Luna Pharma Consulting is a London-based pharmaceutical consulting firm specialising in bringing life-changing medications to patients with rare disorders. The company focuses on the critical gap between pharmaceutical innovation and patient access, working with drug manufacturers to navigate the complex landscape of bringing rare disease treatments to market.
The firm serves pharmaceutical companies at various stages of development, from those with promising candidates seeking market entry strategies to established manufacturers looking to optimise their rare disease portfolios. Their clientele ranges from small biotech firms to larger pharmaceutical organisations seeking specialist expertise in this niche sector.
What distinguishes Luna Pharma Consulting is their clear mission-driven approach. Rather than operating as a generic consultancy, they explicitly position themselves as advocates for patients with rare disorders who previously had limited or no treatment options. This patient-centric philosophy informs their work throughout the drug development and commercialisation process.
The company likely provides guidance on regulatory pathways, reimbursement strategies, health economics, and market access challenges specific to orphan drugs and rare disease treatments. Their London base provides proximity to UK and European regulatory bodies, whilst their expertise extends to navigating international markets.
By combining pharmaceutical expertise with genuine commitment to improving outcomes for vulnerable patient populations, Luna Pharma Consulting addresses a genuine market need where standard consulting approaches often fall short. They transform hope into reality for patients living with rare conditions.
Luna Pharma Consulting is a London-based pharmaceutical consulting firm specialising in bringing life-changing medications to patients with rare disorders. The company focuses on the critical gap between pharmaceutical innovation and patient access, working with drug manufacturers to navigate the complex landscape of bringing rare disease treatments to market.
The firm serves pharmaceutical companies at various stages of development, from those with promising candidates seeking market entry strategies to established manufacturers looking to optimise their rare disease portfolios. Their clientele ranges from small biotech firms to larger pharmaceutical organisations seeking specialist expertise in this niche sector.
What distinguishes Luna Pharma Consulting is their clear mission-driven approach. Rather than operating as a generic consultancy, they explicitly position themselves as advocates for patients with rare disorders who previously had limited or no treatment options. This patient-centric philosophy informs their work throughout the drug development and commercialisation process.
The company likely provides guidance on regulatory pathways, reimbursement strategies, health economics, and market access challenges specific to orphan drugs and rare disease treatments. Their London base provides proximity to UK and European regulatory bodies, whilst their expertise extends to navigating international markets.
By combining pharmaceutical expertise with genuine commitment to improving outcomes for vulnerable patient populations, Luna Pharma Consulting addresses a genuine market need where standard consulting approaches often fall short. They transform hope into reality for patients living with rare conditions.
Services offered
Regulatory pathway guidanceMarket access strategyHealth economics and reimbursementRare disease commercialisationDrug development consultationPatient access programmesOrphan drug strategyInternational market expansion